Aernoud Fiolet

309 Predictors of early intolerance to low-dose colchicine in patients with coronary disease 19. Banach M, Rizzo M, Toth PP, et al. Statin intolerance–an attempt at a unified definition. Position paper from an International Lipid Expert Panel. Arch Med Sci AMS 2015;11(1):1. 20. Erdmann E. Safety and tolerability of beta-blockers: prejudices and reality. Eur Hear J Suppl 2009;11(suppl_A):A21–5. 21. Iacobuzio-Donahue CA, Lee EL, Abraham SC, Yardley JH, Wu T-T. Colchicine toxicity: distinct morphologic findings in gastrointestinal biopsies. Am J Surg Pathol 2001;25(8):1067–73. 22. Rodenburg EM, Stricker BH, Visser LE. Sex differences in cardiovascular drug‐induced adverse reactions causing hospital admissions. Br J Clin Pharmacol 2012;74(6):1045–52. 23. Soldin OP, Mattison DR. Sex differences in pharmacokinetics and pharmacodynamics. Clin Pharmacokinet 2009;48(3):143–57. 24. Ding EL, Powe NR, Manson JE, Sherber NS, Braunstein JB. Sex differences in perceived risks, distrust, and willingness to participate in clinical trials: a randomized study of cardiovascular prevention trials. Arch Intern Med 2007;167(9):905–12. 25. ClinicalTrials.gov. Colchicine for Prevention of Vascular Inflammation in Non-cardio Embolic Stroke (CONVINCE). NCT02898610